Compass Minerals International (CMP) Holder Alps Advisors Has Lowered Its Stake as Stock Price Declined; Rock Springs Capital Management LP Trimmed Medtronic Plc (MDT) Holding by $11.75 Million; Shares Rose

February 17, 2018 - By Marie Mckinney

Alps Advisors Inc decreased its stake in Compass Minerals International (CMP) by 60.48% based on its latest 2017Q3 regulatory filing with the SEC. Alps Advisors Inc sold 6,134 shares as the company’s stock declined 13.15% while stock markets rallied. The institutional investor held 4,009 shares of the basic industries company at the end of 2017Q3, valued at $260,000, down from 10,143 at the end of the previous reported quarter. Alps Advisors Inc who had been investing in Compass Minerals International for a number of months, seems to be less bullish one the $2.12 billion market cap company. The stock decreased 0.32% or $0.2 during the last trading session, reaching $62.8. About 527,656 shares traded or 53.90% up from the average. Compass Minerals International, Inc. (NYSE:CMP) has declined 13.31% since February 17, 2017 and is downtrending. It has underperformed by 30.01% the S&P500.

Rock Springs Capital Management Lp decreased its stake in Medtronic Plc (MDT) by 38.16% based on its latest 2017Q3 regulatory filing with the SEC. Rock Springs Capital Management Lp sold 152,636 shares as the company’s stock rose 5.51% with the market. The hedge fund held 247,364 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $19.24 million, down from 400,000 at the end of the previous reported quarter. Rock Springs Capital Management Lp who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $112.76 billion market cap company. The stock increased 0.45% or $0.37 during the last trading session, reaching $83.31. About 6.86M shares traded or 27.38% up from the average. Medtronic plc (NYSE:MDT) has risen 4.04% since February 17, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Among 8 analysts covering Compass Minerals (NYSE:CMP), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Compass Minerals had 24 analyst reports since August 14, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Hold” rating and $7500 target in Thursday, July 6 report. Monness Crespi & Hardt maintained the stock with “Sell” rating in Wednesday, October 5 report. As per Monday, June 5, the company rating was maintained by BMO Capital Markets. Deutsche Bank maintained Compass Minerals International, Inc. (NYSE:CMP) rating on Friday, August 14. Deutsche Bank has “Hold” rating and $90.0 target. Stifel Nicolaus maintained it with “Buy” rating and $84.0 target in Thursday, August 17 report. The rating was downgraded by Credit Suisse on Thursday, February 15 to “Sell”. On Wednesday, June 15 the stock rating was downgraded by KeyBanc Capital Markets to “Sector Weight”. The rating was maintained by BMO Capital Markets on Wednesday, February 14 with “Hold”. The stock has “Hold” rating by BB&T Capital on Wednesday, March 30. The stock of Compass Minerals International, Inc. (NYSE:CMP) earned “Buy” rating by Monness Crespi & Hardt on Monday, October 2.

Alps Advisors Inc, which manages about $13.32B and $14.11 billion US Long portfolio, upped its stake in Mcewen Mining Inc (NYSE:MUX) by 610,952 shares to 1.22 million shares, valued at $2.37M in 2017Q3, according to the filing. It also increased its holding in Targa Resources Corp (NYSE:TRGP) by 38,656 shares in the quarter, for a total of 140,162 shares, and has risen its stake in Dominion Energy Inc (NYSE:D).

Investors sentiment decreased to 1.41 in 2017 Q3. Its down 0.35, from 1.76 in 2017Q2. It worsened, as 22 investors sold CMP shares while 71 reduced holdings. 30 funds opened positions while 101 raised stakes. 36.34 million shares or 0.88% less from 36.66 million shares in 2017Q2 were reported. Barclays Pcl reported 0% of its portfolio in Compass Minerals International, Inc. (NYSE:CMP). South Dakota Council has invested 0.04% in Compass Minerals International, Inc. (NYSE:CMP). Management Associate Ny, New York-based fund reported 5,800 shares. Guggenheim Lc invested in 0.01% or 75,177 shares. Omers Administration holds 0.01% of its portfolio in Compass Minerals International, Inc. (NYSE:CMP) for 9,659 shares. Dean Investment Ltd owns 97,313 shares. Morgan Stanley holds 243,273 shares or 0% of its portfolio. Viking Fund Mgmt Ltd Llc owns 29,000 shares for 0.3% of their portfolio. Clearbridge Ltd Liability Corporation stated it has 0% of its portfolio in Compass Minerals International, Inc. (NYSE:CMP). Metropolitan Life Communication Ny reported 53,746 shares. Weaver C Barksdale Associates holds 95 shares or 0.01% of its portfolio. Oppenheimer Asset Mgmt holds 20,214 shares. Inv Limited Oh Adv stated it has 0.18% in Compass Minerals International, Inc. (NYSE:CMP). 7,388 are held by City Fl. Tortoise Mgmt Lc holds 0.01% or 325 shares.

Rock Springs Capital Management Lp, which manages about $319.00 million and $2.17 billion US Long portfolio, upped its stake in Nabriva Therapeutics Plc by 100,000 shares to 625,000 shares, valued at $5.12 million in 2017Q3, according to the filing. It also increased its holding in Axogen Inc (NASDAQ:AXGN) by 25,000 shares in the quarter, for a total of 400,000 shares, and has risen its stake in Amicus Therapeutics Inc (NASDAQ:FOLD).

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was maintained by UBS with “Buy” on Friday, February 17. The company was initiated on Tuesday, September 22 by UBS. The company was maintained on Wednesday, November 23 by Needham. Oppenheimer maintained the shares of MDT in report on Monday, June 26 with “Buy” rating. Cowen & Co maintained the stock with “Buy” rating in Tuesday, August 22 report. The rating was maintained by Deutsche Bank with “Buy” on Thursday, June 2. The stock of Medtronic plc (NYSE:MDT) earned “Neutral” rating by Wedbush on Wednesday, June 1. The company was reinitiated on Monday, August 10 by Credit Suisse. The rating was maintained by BMO Capital Markets on Tuesday, October 10 with “Outperform”. Jefferies maintained Medtronic plc (NYSE:MDT) on Friday, September 4 with “Hold” rating.

Analysts await Medtronic plc (NYSE:MDT) to report earnings on February, 20. They expect $1.17 EPS, up 4.46% or $0.05 from last year’s $1.12 per share. MDT’s profit will be $1.58B for 17.80 P/E if the $1.17 EPS becomes a reality. After $1.07 actual EPS reported by Medtronic plc for the previous quarter, Wall Street now forecasts 9.35% EPS growth.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.22, from 0.9 in 2017Q2. It improved, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Financial Corporation has invested 0.11% in Medtronic plc (NYSE:MDT). Tci Wealth, a Arizona-based fund reported 7,336 shares. Wunderlich Capital Managemnt stated it has 1.12% of its portfolio in Medtronic plc (NYSE:MDT). 351,522 were reported by Waddell & Reed Fincl. Peak6 Invests Ltd Partnership owns 16,212 shares or 0.01% of their US portfolio. Advisor Limited Liability Company stated it has 0.22% in Medtronic plc (NYSE:MDT). Amp holds 0.3% of its portfolio in Medtronic plc (NYSE:MDT) for 694,405 shares. Tcw Grp Inc has invested 0.5% in Medtronic plc (NYSE:MDT). Mark Sheptoff Planning Limited Liability Corporation reported 7,889 shares stake. Nippon Life Co invested in 45,384 shares or 0.07% of the stock. Meeder Asset Mgmt Incorporated reported 34,553 shares. First Foundation invested in 1.55% or 350,772 shares. Brown Advisory holds 0.02% of its portfolio in Medtronic plc (NYSE:MDT) for 64,260 shares. Saratoga Research And Mgmt reported 0% of its portfolio in Medtronic plc (NYSE:MDT). Sumitomo Life Ins owns 55,029 shares or 0.55% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: